← Open Payments lookup

ANTHONY SIMS: Open Payments

NPI 1992786636 · HENAGAR, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$794 in 44 payments from 17 companies in 2025. Trend: 2023 $555 · 2024 $827 · 2025 $794

Food & beverage: $794
CompanyPaymentsAmount
GlaxoSmithKline, LLC.13$172
Novo Nordisk Inc8$153
Corcept Therapeutics3$71
ABBVIE INC.3$64
Indivior Inc.2$50
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$39
AstraZeneca Pharmaceuticals LP2$33
Boehringer Ingelheim Pharmaceuticals, Inc.2$32
Dexcom, Inc.1$30
Sumitomo Pharma America, Inc.1$23

Products named: TRELEGY ELLIPTA, Ozempic, Korlym, SHINGRIX, VRAYLAR, JARDIANCE, SUBLOCADE, Rybelsus.

Industry payments across AL — which companies pay providers there.